25 XP   0   0   10

Inovio Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Inovio together

PenkeI guess you are interested in Inovio Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Inovio Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Inovio Pharmaceuticals Inc

I send you an email if I find something interesting about Inovio Pharmaceuticals Inc.

Quick analysis of Inovio (30 sec.)










What can you expect buying and holding a share of Inovio? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$5.02
Expected worth in 1 year
$9.11
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$4.09
Return On Investment
29.5%

For what price can you sell your share?

Current Price per Share
$13.88
Expected price per share
$8.3486 - $16.68
How sure are you?
50%

1. Valuation of Inovio (5 min.)




Live pricePrice per Share (EOD)

$13.88

Intrinsic Value Per Share

$-46.40 - $-26.97

Total Value Per Share

$-41.38 - $-21.95

2. Growth of Inovio (5 min.)




Is Inovio growing?

Current yearPrevious yearGrowGrow %
How rich?$117.3m$285.4m-$129.4m-83.0%

How much money is Inovio making?

Current yearPrevious yearGrowGrow %
Making money$713.5m-$71.9m$785.4m110.1%
Net Profit Margin629,140.3%-24,592.1%--

How much money comes from the company's main activities?

3. Financial Health of Inovio (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#358 / 1031

Most Revenue
#587 / 1031

Most Profit
#7 / 1031

What can you expect buying and holding a share of Inovio? (5 min.)

Welcome investor! Inovio's management wants to use your money to grow the business. In return you get a share of Inovio.

What can you expect buying and holding a share of Inovio?

First you should know what it really means to hold a share of Inovio. And how you can make/lose money.

Speculation

The Price per Share of Inovio is $13.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inovio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inovio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.02. Based on the TTM, the Book Value Change Per Share is $1.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inovio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.07-7.7%-0.37-2.7%-0.30-2.2%-0.32-2.3%-0.26-1.9%
Usd Book Value Change Per Share4.5132.5%1.027.4%-0.24-1.7%0.211.5%0.100.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share4.5132.5%1.027.4%-0.24-1.7%0.211.5%0.100.7%
Usd Price Per Share0.51-0.54-2.15-5.42-6.19-
Price to Earnings Ratio-0.12--0.76--1.99--2.44--5.63-
Price-to-Total Gains Ratio0.11--2.87--9.47--7.61--26.29-
Price to Book Ratio0.10-0.65-1.72-7.54-5.73-
Price-to-Total Gains Ratio0.11--2.87--9.47--7.61--26.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.88
Number of shares72
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.020.21
Usd Total Gains Per Share1.020.21
Gains per Quarter (72 shares)73.6114.86
Gains per Year (72 shares)294.4459.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1029428405949
205895780119108
308838720178167
40117811660238226
50147214600297285
60176717540357344
70206120480416403
80235623420476462
90265026360535521
100294429300595580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%2.038.00.05.0%5.095.00.05.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.031.00.022.5%27.073.00.027.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%2.00.038.05.0%16.00.084.016.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.031.00.022.5%28.072.00.028.0%

Fundamentals of Inovio

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Fundamental data was last updated by Penke on 2024-03-19 16:02:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Inovio Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Inovio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • A Net Profit Margin of -24,357.9% means that $-243.58 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inovio Pharmaceuticals Inc:

  • The MRQ is -24,357.9%. The company is making a huge loss. -2
  • The TTM is 629,140.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-24,357.9%TTM629,140.3%-653,498.2%
TTM629,140.3%YOY-24,592.1%+653,732.3%
TTM629,140.3%5Y112,914.1%+516,226.2%
5Y112,914.1%10Y56,221.5%+56,692.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24,357.9%-159.2%-24,198.7%
TTM629,140.3%-202.3%+629,342.6%
YOY-24,592.1%-263.0%-24,329.1%
5Y112,914.1%-452.4%+113,366.5%
10Y56,221.5%-589.0%+56,810.5%
1.1.2. Return on Assets

Shows how efficient Inovio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • -14.5% Return on Assets means that Inovio generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inovio Pharmaceuticals Inc:

  • The MRQ is -14.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 264.7%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-14.5%TTM264.7%-279.2%
TTM264.7%YOY-17.1%+281.8%
TTM264.7%5Y41.1%+223.6%
5Y41.1%10Y15.6%+25.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.5%-12.5%-2.0%
TTM264.7%-12.2%+276.9%
YOY-17.1%-11.2%-5.9%
5Y41.1%-13.3%+54.4%
10Y15.6%-14.6%+30.2%
1.1.3. Return on Equity

Shows how efficient Inovio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • -21.3% Return on Equity means Inovio generated $-0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inovio Pharmaceuticals Inc:

  • The MRQ is -21.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 353.3%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-21.3%TTM353.3%-374.6%
TTM353.3%YOY-24.9%+378.2%
TTM353.3%5Y-4.8%+358.1%
5Y-4.8%10Y-9.0%+4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.3%-16.0%-5.3%
TTM353.3%-15.8%+369.1%
YOY-24.9%-13.9%-11.0%
5Y-4.8%-18.2%+13.4%
10Y-9.0%-19.1%+10.1%

1.2. Operating Efficiency of Inovio Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Inovio is operating .

  • Measures how much profit Inovio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • An Operating Margin of -26,686.3% means the company generated $-266.86  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inovio Pharmaceuticals Inc:

  • The MRQ is -26,686.3%. The company is operating very inefficient. -2
  • The TTM is -22,584.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-26,686.3%TTM-22,584.5%-4,101.8%
TTM-22,584.5%YOY-23,644.2%+1,059.7%
TTM-22,584.5%5Y-15,693.0%-6,891.5%
5Y-15,693.0%10Y-8,086.2%-7,606.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26,686.3%-299.5%-26,386.8%
TTM-22,584.5%-208.5%-22,376.0%
YOY-23,644.2%-280.2%-23,364.0%
5Y-15,693.0%-459.9%-15,233.1%
10Y-8,086.2%-596.9%-7,489.3%
1.2.2. Operating Ratio

Measures how efficient Inovio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 267.86 means that the operating costs are $267.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 267.863. The company is inefficient in keeping operating costs low. -1
  • The TTM is 294.736. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ267.863TTM294.736-26.873
TTM294.736YOY240.184+54.552
TTM294.7365Y192.959+101.777
5Y192.95910Y101.884+91.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ267.8632.817+265.046
TTM294.7363.181+291.555
YOY240.1843.609+236.575
5Y192.9595.554+187.405
10Y101.8847.396+94.488

1.3. Liquidity of Inovio Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Inovio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.60 means the company has $3.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 3.597. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.938. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.597TTM3.938-0.341
TTM3.938YOY4.214-0.277
TTM3.9385Y6.505-2.567
5Y6.50510Y6.149+0.356
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5973.987-0.390
TTM3.9384.440-0.502
YOY4.2145.569-1.355
5Y6.5056.158+0.347
10Y6.1496.492-0.343
1.3.2. Quick Ratio

Measures if Inovio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • A Quick Ratio of 6.55 means the company can pay off $6.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 6.546. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.028. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.546TTM7.028-0.482
TTM7.028YOY6.740+0.288
TTM7.0285Y10.142-3.115
5Y10.14210Y9.399+0.744
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5463.653+2.893
TTM7.0284.158+2.870
YOY6.7405.515+1.225
5Y10.1426.012+4.130
10Y9.3996.206+3.193

1.4. Solvency of Inovio Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Inovio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inovio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.32 means that Inovio assets are financed with 32.1% credit (debt) and the remaining percentage (100% - 32.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.321. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.283. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.321TTM0.283+0.038
TTM0.283YOY0.309-0.026
TTM0.2835Y0.368-0.085
5Y0.36810Y0.290+0.078
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3210.336-0.015
TTM0.2830.330-0.047
YOY0.3090.267+0.042
5Y0.3680.367+0.001
10Y0.2900.378-0.088
1.4.2. Debt to Equity Ratio

Measures if Inovio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inovio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 47.4% means that company has $0.47 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inovio Pharmaceuticals Inc:

  • The MRQ is 0.474. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.396. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.474TTM0.396+0.077
TTM0.396YOY0.459-0.062
TTM0.3965Y2.703-2.306
5Y2.70310Y1.491+1.211
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4740.376+0.098
TTM0.3960.398-0.002
YOY0.4590.334+0.125
5Y2.7030.431+2.272
10Y1.4910.476+1.015

2. Market Valuation of Inovio Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inovio generates.

  • Above 15 is considered overpriced but always compare Inovio to the Biotechnology industry mean.
  • A PE ratio of -0.12 means the investor is paying $-0.12 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inovio Pharmaceuticals Inc:

  • The EOD is -3.243. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.119. Based on the earnings, the company is expensive. -2
  • The TTM is -0.756. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.243MRQ-0.119-3.124
MRQ-0.119TTM-0.756+0.637
TTM-0.756YOY-1.994+1.239
TTM-0.7565Y-2.438+1.683
5Y-2.43810Y-5.633+3.195
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.243-2.697-0.546
MRQ-0.119-2.422+2.303
TTM-0.756-2.709+1.953
YOY-1.994-4.116+2.122
5Y-2.438-6.257+3.819
10Y-5.633-6.478+0.845
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inovio Pharmaceuticals Inc:

  • The EOD is -3.086. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.113. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.792. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.086MRQ-0.113-2.973
MRQ-0.113TTM-0.792+0.679
TTM-0.792YOY-2.352+1.560
TTM-0.7925Y-5.950+5.158
5Y-5.95010Y-7.530+1.580
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.086-3.344+0.258
MRQ-0.113-2.939+2.826
TTM-0.792-3.486+2.694
YOY-2.352-5.592+3.240
5Y-5.950-8.464+2.514
10Y-7.530-8.872+1.342
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Inovio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.10 means the investor is paying $0.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inovio Pharmaceuticals Inc:

  • The EOD is 2.764. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.102. Based on the equity, the company is cheap. +2
  • The TTM is 0.655. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.764MRQ0.102+2.663
MRQ0.102TTM0.655-0.553
TTM0.655YOY1.717-1.062
TTM0.6555Y7.544-6.890
5Y7.54410Y5.729+1.816
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7642.198+0.566
MRQ0.1022.042-1.940
TTM0.6552.121-1.466
YOY1.7172.907-1.190
5Y7.5443.682+3.862
10Y5.7294.114+1.615
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Inovio Pharmaceuticals Inc.

3.1. Institutions holding Inovio Pharmaceuticals Inc

Institutions are holding 18.504% of the shares of Inovio Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc7.35380.00022007483269490.0346
2023-09-30BlackRock Inc2.16830.00015919146-167477-2.7516
2023-09-30D. E. Shaw & Co LP2.02160.00225518837-2083296-27.4041
2023-09-30Renaissance Technologies Corp1.79110.00324889500-546781-10.058
2023-09-30Millennium Management LLC1.67720.00094578455-761798-14.2652
2023-09-30Geode Capital Management, LLC1.00770.00012751018-110225-3.8523
2023-09-30Jacobs Levy Equity Management, Inc.0.42130.00271149974-997345-46.4461
2023-09-30State Street Corporation0.31910871047-6400-0.7294
2023-09-30Two Sigma Investments LLC0.30380.0009829238-969002-53.8861
2023-09-30Northern Trust Corp0.17550479006132532.8455
2023-09-30Acadian Asset Management LLC0.16860.00084602004394002112.5
2023-12-31Green Alpha Advisors, LLC0.16550.1661451725-118324-20.7568
2023-09-30Bank of America Corp0.15170414139-255821-38.1845
2023-09-30Amvescap Plc.0.12110330477204896.6096
2023-09-30Morgan Stanley - Brokerage Accounts0.11140304237-72440-19.2313
2023-09-30Verition Fund Managegment, LLC0.10990.00143000457504533.3533
2023-09-30GSA Capital Partners LLP0.10880.00992969482969480
2023-09-30JANE STREET GROUP, LLC0.09840268650-2927431-91.5944
2023-09-30FMR Inc0.06790185334160024632.256
2023-09-30Susquehanna International Group, LLP0.06140167669-589744-77.8629
Total 18.40410.188550240477-8593976-17.1%

3.2. Funds holding Inovio Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Strategic Small-Cap Equity Inv1.33970.12533657265-398543-9.8265
2023-12-31Vanguard Strategic Equity Inv1.09960.0197300174000
2024-02-29Vanguard Total Stock Mkt Idx Inv3.02590.0004688368-1-0.0001
2023-09-30BlackRock Extended Mkt Composite0.21030.001657418100
2023-12-31BlackRock Extended Equity Market K0.18350.0019500925-1009-0.201
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.44610.00293289773972913.7353
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.10270.00232804627722037.9941
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08390.00222901600
2023-12-31Northern Trust Extended Eq Market Idx0.08390.00222901600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.08250.00232252506232538.2538
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.07170.0003195712-8064716-97.6307
2023-12-31T. Rowe Price U.S. Equities Tr0.05490.000815000000
2024-01-31Fidelity Extended Market Index0.55680.001912667650.0039
2023-12-31Franklin U.S. Small Cap Equity I0.03440.05049397200
2023-12-31SSgA U.S. Extended Market Index Class I0.03230.00178819900
2023-12-31BlackRock U.S. Equity Market F0.0290.0003792971420.1794
2024-02-29Vanguard Health Care ETF0.33630.0033764993840.5045
2023-12-31Fidelity Inst TM TPI U.S. All Cap0.02780.03037580853156234.6636
2023-12-31Extended Equity Market Fund M0.02270.00196193829484.9975
2024-01-31Fidelity Total Market Index0.18250.000341516570715.9373
Total 9.00650.251610704817-8222653-76.8%

3.3. Insider Transactions

Insiders are holding 1.607% of the shares of Inovio Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-03-13David B WeinerSELL40165.6
2023-02-27David B WeinerSELL81184.32
2022-08-11David B WeinerSELL82383.04
2022-07-20Simon X BenitoSELL13324
2022-03-16Simon X BenitoSELL13455.04
2022-03-14David B WeinerSELL28460.8
2022-01-19Simon X BenitoSELL13614.88
2021-06-09Jacqueline Elizabeth SheaSELL2671441.44
2021-06-09Laurent HumeauSELL711306.08
2021-06-09Peter KiesSELL2341441.44
2021-06-03Peter KiesSELL691156.32
2021-05-17Lota S ZothSELL14953.28
2021-04-21David B. WeinerSELL1841234.08
2021-04-21Peter KiesSELL691226.88
2021-04-16Simon X BenitoSELL131260
2021-03-26Jacqueline Elizabeth SheaSELL321291.68

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Inovio Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.5071.022+341%-0.242+105%0.206+2083%0.102+4338%
Book Value Per Share--5.0211.737+189%1.222+311%1.517+231%1.678+199%
Current Ratio--3.5973.938-9%4.214-15%6.505-45%6.149-42%
Debt To Asset Ratio--0.3210.283+14%0.309+4%0.368-13%0.290+11%
Debt To Equity Ratio--0.4740.396+20%0.459+3%2.703-82%1.491-68%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---1.070-0.372-65%-0.301-72%-0.320-70%-0.264-75%
Free Cash Flow Per Share---1.124-0.382-66%-0.229-80%-0.279-75%-0.225-80%
Free Cash Flow To Equity Per Share---1.046-0.357-66%-0.140-87%0.013-8462%0.025-4340%
Gross Profit Margin--1.0071.002+1%1.000+1%1.000+1%1.000+1%
Intrinsic Value_10Y_max---26.967--------
Intrinsic Value_10Y_min---46.404--------
Intrinsic Value_1Y_max---1.161--------
Intrinsic Value_1Y_min---1.765--------
Intrinsic Value_3Y_max---4.663--------
Intrinsic Value_3Y_min---7.834--------
Intrinsic Value_5Y_max---9.582--------
Intrinsic Value_5Y_min---16.629--------
Market Cap324381152.000+96%11918904.000111591516.708-89%498852407.033-98%935220532.852-99%721545060.727-98%
Net Profit Margin---243.5796291.403-104%-245.921+1%1129.141-122%562.215-143%
Operating Margin---266.863-225.845-15%-236.442-11%-156.930-41%-80.862-70%
Operating Ratio--267.863294.736-9%240.184+12%192.959+39%101.884+163%
Pb Ratio2.764+96%0.1020.655-84%1.717-94%7.544-99%5.729-98%
Pe Ratio-3.243-2622%-0.119-0.756+534%-1.994+1574%-2.438+1946%-5.633+4627%
Price Per Share13.880+96%0.5100.541-6%2.151-76%5.417-91%6.191-92%
Price To Free Cash Flow Ratio-3.086-2622%-0.113-0.792+598%-2.352+1974%-5.950+5147%-7.530+6540%
Price To Total Gains Ratio3.080+96%0.113-2.872+2638%-9.471+8470%-7.609+6824%-26.293+23336%
Quick Ratio--6.5467.028-7%6.740-3%10.142-35%9.399-30%
Return On Assets---0.1452.647-105%-0.171+18%0.411-135%0.156-193%
Return On Equity---0.2133.533-106%-0.249+17%-0.048-78%-0.090-58%
Total Gains Per Share--4.5071.022+341%-0.242+105%0.206+2083%0.102+4334%
Usd Book Value--117349129.000156023523.000-25%285453996.500-59%252381757.850-54%193361060.250-39%
Usd Book Value Change Per Share--4.5071.022+341%-0.242+105%0.206+2083%0.102+4338%
Usd Book Value Per Share--5.0211.737+189%1.222+311%1.517+231%1.678+199%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---1.070-0.372-65%-0.301-72%-0.320-70%-0.264-75%
Usd Free Cash Flow---26275785.000-33104032.750+26%-53796144.000+105%-42143900.550+60%-27623340.075+5%
Usd Free Cash Flow Per Share---1.124-0.382-66%-0.229-80%-0.279-75%-0.225-80%
Usd Free Cash Flow To Equity Per Share---1.046-0.357-66%-0.140-87%0.013-8462%0.025-4340%
Usd Market Cap324381152.000+96%11918904.000111591516.708-89%498852407.033-98%935220532.852-99%721545060.727-98%
Usd Price Per Share13.880+96%0.5100.541-6%2.151-76%5.417-91%6.191-92%
Usd Profit---25003638.000713563912.000-104%-71916059.250+188%98858116.250-125%41323476.625-161%
Usd Revenue--102651.000208002.750-51%2565567.000-96%1219609.250-92%4587285.150-98%
Usd Total Gains Per Share--4.5071.022+341%-0.242+105%0.206+2083%0.102+4334%
 EOD+6 -2MRQTTM+12 -22YOY+15 -195Y+13 -2110Y+12 -24

4.2. Fundamental Score

Let's check the fundamental score of Inovio Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.243
Price to Book Ratio (EOD)Between0-12.764
Net Profit Margin (MRQ)Greater than0-243.579
Operating Margin (MRQ)Greater than0-266.863
Quick Ratio (MRQ)Greater than16.546
Current Ratio (MRQ)Greater than13.597
Debt to Asset Ratio (MRQ)Less than10.321
Debt to Equity Ratio (MRQ)Less than10.474
Return on Equity (MRQ)Greater than0.15-0.213
Return on Assets (MRQ)Greater than0.05-0.145
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Inovio Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5077.791
Ma 20Greater thanMa 5011.048
Ma 50Greater thanMa 1008.622
Ma 100Greater thanMa 2007.155
OpenGreater thanClose13.000
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -2,795-2,986,578-2,989,3732,988,415-958-75-1,0331,0330



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets172,944
Total Liabilities55,595
Total Stockholder Equity117,349
 As reported
Total Liabilities 55,595
Total Stockholder Equity+ 117,349
Total Assets = 172,944

Assets

Total Assets172,944
Total Current Assets153,113
Long-term Assets19,831
Total Current Assets
Cash And Cash Equivalents 14,311
Short-term Investments 130,983
Net Receivables 2,405
Other Current Assets 5,414
Total Current Assets  (as reported)153,113
Total Current Assets  (calculated)153,113
+/-0
Long-term Assets
Property Plant Equipment 14,453
Long Term Investments 2,780
Long-term Assets Other 605
Long-term Assets  (as reported)19,831
Long-term Assets  (calculated)17,838
+/- 1,993

Liabilities & Shareholders' Equity

Total Current Liabilities42,570
Long-term Liabilities13,025
Total Stockholder Equity117,349
Total Current Liabilities
Short-term Debt 19,177
Short Long Term Debt 16,771
Accounts payable 4,648
Other Current Liabilities 18,745
Total Current Liabilities  (as reported)42,570
Total Current Liabilities  (calculated)59,341
+/- 16,771
Long-term Liabilities
Capital Lease Obligations 13,439
Long-term Liabilities  (as reported)13,025
Long-term Liabilities  (calculated)13,439
+/- 414
Total Stockholder Equity
Common Stock23
Retained Earnings -1,622,965
Accumulated Other Comprehensive Income -663
Other Stockholders Equity 1,740,954
Total Stockholder Equity (as reported)117,349
Total Stockholder Equity (calculated)117,349
+/-0
Other
Capital Stock23
Cash and Short Term Investments 145,294
Common Stock Shares Outstanding 22,793
Liabilities and Stockholders Equity 172,944
Net Debt 15,898
Net Invested Capital 134,120
Net Working Capital 110,543
Property Plant and Equipment Gross 35,305
Short Long Term Debt Total 30,209



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-31
> Total Assets 
12,100
9,800
18,200
16,600
15,200
14,012
12,712
11,012
9,184
11,484
8,907
7,064
11,484
4,256
7,881
6,552
5,419
4,979
3,653
9,953
16,229
15,685
24,676
22,627
20,952
22,881
20,149
15,916
28,979
25,978
23,025
19,902
35,950
31,919
44,353
40,865
39,775
35,717
32,265
30,481
38,987
35,984
63,273
90,438
80,629
79,722
60,277
59,317
56,067
74,854
67,858
63,266
61,107
55,351
48,596
44,476
45,139
58,201
50,993
88,015
88,287
151,658
142,153
134,533
131,785
117,855
201,703
230,772
213,841
211,288
203,985
194,549
173,707
153,314
158,853
203,680
187,239
173,665
148,923
140,696
131,113
191,166
165,073
151,533
143,952
338,921
443,185
437,814
539,772
654,863
591,842
535,763
495,941
445,511
459,399
391,968
348,533
266,583
233,038
193,097
172,944
172,944193,097233,038266,583348,533391,968459,399445,511495,941535,763591,842654,863539,772437,814443,185338,921143,952151,533165,073191,166131,113140,696148,923173,665187,239203,680158,853153,314173,707194,549203,985211,288213,841230,772201,703117,855131,785134,533142,153151,65888,28788,01550,99358,20145,13944,47648,59655,35161,10763,26667,85874,85456,06759,31760,27779,72280,62990,43863,27335,98438,98730,48132,26535,71739,77540,86544,35331,91935,95019,90223,02525,97828,97915,91620,14922,88120,95222,62724,67615,68516,2299,9533,6534,9795,4196,5527,8814,25611,4847,0648,90711,4849,18411,01212,71214,01215,20016,60018,2009,80012,100
   > Total Current Assets 
9,900
7,600
15,900
14,400
12,900
11,614
10,290
8,050
5,821
8,247
5,772
3,867
8,247
3,608
5,114
3,832
2,698
2,357
1,093
7,438
13,752
13,217
22,239
20,203
18,439
12,989
10,327
6,188
18,321
15,289
12,139
9,102
24,472
20,430
32,985
29,621
29,004
12,369
9,229
7,900
15,264
12,425
24,258
48,431
44,567
43,122
27,316
24,272
22,877
42,483
38,607
32,734
31,907
26,936
21,317
16,934
15,968
30,316
25,537
57,854
58,684
121,684
112,944
104,637
98,947
87,330
162,141
184,073
171,851
160,601
147,970
140,230
124,597
106,779
106,878
154,588
138,362
123,836
101,841
93,603
87,815
134,903
110,509
98,813
94,201
275,544
382,062
377,065
471,171
588,435
542,425
487,397
448,445
399,907
416,185
350,208
315,243
233,896
203,284
174,767
153,113
153,113174,767203,284233,896315,243350,208416,185399,907448,445487,397542,425588,435471,171377,065382,062275,54494,20198,813110,509134,90387,81593,603101,841123,836138,362154,588106,878106,779124,597140,230147,970160,601171,851184,073162,14187,33098,947104,637112,944121,68458,68457,85425,53730,31615,96816,93421,31726,93631,90732,73438,60742,48322,87724,27227,31643,12244,56748,43124,25812,42515,2647,9009,22912,36929,00429,62132,98520,43024,4729,10212,13915,28918,3216,18810,32712,98918,43920,20322,23913,21713,7527,4381,0932,3572,6983,8325,1143,6088,2473,8675,7728,2475,8218,05010,29011,61412,90014,40015,9007,6009,900
       Cash And Cash Equivalents 
8,800
6,200
14,500
3,800
4,500
9,742
8,253
6,028
3,287
3,721
4,005
2,206
3,721
1,813
1,429
1,365
875
2,023
924
7,359
13,460
13,129
22,068
19,740
17,890
11,810
6,909
4,977
17,167
2,220
1,873
1,940
8,322
6,334
7,786
7,087
10,251
8,282
8,107
6,411
14,115
11,727
8,283
32,509
30,296
17,711
14,952
19,392
19,998
37,182
30,594
25,303
17,350
11,129
5,952
4,589
5,646
20,087
10,352
33,067
33,720
98,771
88,535
70,669
40,544
26,146
70,298
85,469
57,633
41,624
28,450
23,251
19,136
22,903
23,861
23,278
23,787
37,509
15,086
19,398
23,694
20,779
19,736
15,853
22,196
158,447
215,433
178,700
250,728
83,634
58,925
67,941
71,144
59,009
41,102
21,988
46,329
28,238
52,713
18,805
14,311
14,31118,80552,71328,23846,32921,98841,10259,00971,14467,94158,92583,634250,728178,700215,433158,44722,19615,85319,73620,77923,69419,39815,08637,50923,78723,27823,86122,90319,13623,25128,45041,62457,63385,46970,29826,14640,54470,66988,53598,77133,72033,06710,35220,0875,6464,5895,95211,12917,35025,30330,59437,18219,99819,39214,95217,71130,29632,5098,28311,72714,1156,4118,1078,28210,2517,0877,7866,3348,3221,9401,8732,22017,1674,9776,90911,81017,89019,74022,06813,12913,4607,3599242,0238751,3651,4291,8133,7212,2064,0053,7213,2876,0288,2539,7424,5003,80014,5006,2008,800
       Short-term Investments 
0
0
0
8,800
6,400
0
0
0
688
2,804
0
0
2,804
0
1,989
994
0
0
0
0
0
0
0
0
0
0
0
0
0
12,000
9,000
5,700
14,700
12,700
23,811
21,363
17,000
2,991
0
0
0
0
13,512
10,420
13,543
18,836
9,748
4,110
1,846
3,664
5,760
5,764
12,863
13,730
13,487
10,555
8,034
7,978
13,108
13,105
18,906
18,011
20,323
30,259
53,076
54,867
84,296
85,314
105,357
105,163
106,083
96,436
85,629
66,755
68,139
118,612
103,639
75,260
80,509
66,097
57,539
107,216
86,236
77,946
67,338
111,551
156,231
158,536
160,915
434,970
384,752
326,999
330,171
301,384
307,023
259,895
206,669
195,513
142,213
148,669
130,983
130,983148,669142,213195,513206,669259,895307,023301,384330,171326,999384,752434,970160,915158,536156,231111,55167,33877,94686,236107,21657,53966,09780,50975,260103,639118,61268,13966,75585,62996,436106,083105,163105,35785,31484,29654,86753,07630,25920,32318,01118,90613,10513,1087,9788,03410,55513,48713,73012,8635,7645,7603,6641,8464,1109,74818,83613,54310,42013,51200002,99117,00021,36323,81112,70014,7005,7009,00012,00000000000000009941,98902,804002,8046880006,4008,800000
       Net Receivables 
500
800
600
800
1,000
1,120
999
982
823
904
792
849
904
940
55
9
76
171
3
0
175
7
0
351
424
461
2,524
282
284
432
385
304
326
249
363
293
1,140
477
561
740
671
243
1,420
1,339
318
3,405
2,188
216
105
170
438
455
506
916
466
616
867
1,073
540
10,574
3,302
2,718
2,877
1,622
2,804
3,300
5,609
10,965
7,333
11,153
10,366
17,455
16,570
11,098
8,712
7,162
6,490
7,390
2,673
4,399
4,055
4,079
1,127
1,755
2,032
1,276
3,996
8,194
19,064
10,259
13,851
7,125
8,032
7,491
11,372
2,443
11,738
5,035
5,116
2,144
2,405
2,4052,1445,1165,03511,7382,44311,3727,4918,0327,12513,85110,25919,0648,1943,9961,2762,0321,7551,1274,0794,0554,3992,6737,3906,4907,1628,71211,09816,57017,45510,36611,1537,33310,9655,6093,3002,8041,6222,8772,7183,30210,5745401,0738676164669165064554381701052162,1883,4053181,3391,4202436717405614771,1402933632493263043854322842822,5244614243510717503171769559409048497929048239829991,1201,000800600800500
       Inventory 
500
700
800
800
900
612
837
978
962
757
876
763
757
848
22
30
229
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178
178
0
464
0
0
0
0
0
0
0
0
0
0
63
63
63
63
62
62
62
62
343
343
343
343
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,231
0
0
003,23100000000000000000000000000000034334334334362626262636363630000000000464017817800000000000000000000000002293022848757763876757962978837612900800800700500
       Other Current Assets 
100
-100
0
200
100
139
200
63
61
61
99
48
6
6
1,618
1,433
1,517
163
165
79
117
81
171
112
125
717
893
929
870
637
880
1,158
1,124
1,147
1,026
879
614
619
561
748
477
454
866
3,114
410
2,706
428
555
927
1,467
1,814
1,212
1,187
1,162
1,412
1,174
1,358
1,116
1,474
1,045
2,695
2,122
1,147
2,024
2,180
2,675
1,597
1,983
1,528
2,661
3,070
3,088
3,261
6,023
6,166
5,536
4,447
3,677
3,572
3,709
2,527
2,828
3,410
3,259
2,635
4,270
6,403
31,634
40,464
59,572
84,896
85,331
39,098
32,022
56,689
65,882
50,506
5,110
12
5,150
5,414
5,4145,150125,11050,50665,88256,68932,02239,09885,33184,89659,57240,46431,6346,4034,2702,6353,2593,4102,8282,5273,7093,5723,6774,4475,5366,1666,0233,2613,0883,0702,6611,5281,9831,5972,6752,1802,0241,1472,1222,6951,0451,4741,1161,3581,1741,4121,1621,1871,2121,8141,4679275554282,7064103,1148664544777485616196148791,0261,1471,1241,15888063787092989371712511217181117791651631,5171,4331,6186648996161632001391002000-100100
   > Long-term Assets 
2,200
2,200
2,300
2,200
2,300
2,398
2,422
2,961
3,363
3,237
3,136
3,197
3,237
648
2,767
2,720
2,721
2,622
2,560
2,515
2,477
2,468
2,438
2,423
2,513
9,892
9,823
9,728
10,658
10,689
10,887
10,801
11,478
11,489
11,368
11,244
10,771
23,348
23,036
22,582
23,723
23,559
39,015
42,007
36,062
36,599
32,961
35,045
33,190
32,371
29,251
30,533
29,199
28,415
27,279
27,542
29,171
27,885
25,456
30,161
29,604
29,973
29,209
29,896
32,838
30,526
39,562
46,698
41,990
50,687
56,016
54,319
49,110
46,535
51,976
49,092
48,877
49,829
47,082
47,094
43,298
56,263
54,564
52,721
49,751
63,377
61,123
60,749
68,602
66,429
49,418
48,366
47,497
45,604
43,214
41,760
33,291
32,686
29,753
18,330
19,831
19,83118,33029,75332,68633,29141,76043,21445,60447,49748,36649,41866,42968,60260,74961,12363,37749,75152,72154,56456,26343,29847,09447,08249,82948,87749,09251,97646,53549,11054,31956,01650,68741,99046,69839,56230,52632,83829,89629,20929,97329,60430,16125,45627,88529,17127,54227,27928,41529,19930,53329,25132,37133,19035,04532,96136,59936,06242,00739,01523,55923,72322,58223,03623,34810,77111,24411,36811,48911,47810,80110,88710,68910,6589,7289,8239,8922,5132,4232,4382,4682,4772,5152,5602,6222,7212,7202,7676483,2373,1973,1363,2373,3632,9612,4222,3982,3002,2002,3002,2002,200
       Property Plant Equipment 
1,200
1,200
1,100
1,000
900
1,015
989
973
994
904
834
731
648
648
434
366
295
249
218
198
176
153
165
170
155
423
405
411
376
507
471
459
391
414
386
371
402
378
403
404
354
309
466
382
343
340
383
341
277
304
306
289
296
355
422
392
363
363
348
2,291
2,887
3,021
4,549
4,634
4,583
4,947
5,497
6,459
7,307
8,393
8,701
8,991
9,025
9,803
15,018
18,471
18,320
17,486
16,869
16,228
15,949
29,618
28,488
27,519
26,556
25,616
24,589
24,199
24,089
23,393
30,285
29,457
29,024
27,948
27,126
26,165
17,956
16,849
15,793
14,730
14,453
14,45314,73015,79316,84917,95626,16527,12627,94829,02429,45730,28523,39324,08924,19924,58925,61626,55627,51928,48829,61815,94916,22816,86917,48618,32018,47115,0189,8039,0258,9918,7018,3937,3076,4595,4974,9474,5834,6344,5493,0212,8872,2913483633633924223552962893063042773413833403433824663093544044033784023713864143914594715073764114054231551701651531761982182492953664346486487318349049949739891,0159001,0001,1001,2001,200
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,157
3,157
3,157
4,291
4,291
4,291
4,291
4,291
4,291
4,291
4,291
3,901
3,901
3,901
3,901
3,901
3,901
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,113
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
10,513
0
0
0010,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,51310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,11310,1133,9013,9013,9013,9013,9013,9014,2914,2914,2914,2914,2914,2914,2914,2913,1573,1573,1570000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,384
10,149
9,172
8,804
0
0
0
0
0
0
0
0
0
0
12,891
0
0
0
19,993
0
0
0
19,830
0
0
0
9,069
13,775
11,682
12,700
6,382
6,430
6,325
7,997
6,315
21,211
2,717
958
434
3,630
3,909
3,887
3,907
3,369
2,435
2,130
2,007
2,624
2,781
2,995
2,780
2,7802,9952,7812,6242,0072,1302,4353,3693,9073,8873,9093,6304349582,71721,2116,3157,9976,3256,4306,38212,70011,68213,7759,06900019,83000019,99300012,89100000000008,8049,17210,1498,38400000000000000000000000000000000000000000000000000
       Intangible Assets 
0
1,000
0
0
0
1,350
0
0
0
2,306
0
0
2,351
0
0
0
2,426
2,426
0
0
2,253
0
0
0
2,188
9,469
9,417
9,317
5,992
5,892
6,125
6,051
6,664
6,784
6,691
6,301
6,186
6,066
5,962
5,938
10,132
9,648
13,942
13,453
12,969
12,488
12,133
11,655
11,180
10,709
10,239
9,773
9,310
8,850
8,393
7,940
7,489
7,041
6,596
6,157
5,719
5,479
5,241
5,007
4,776
4,553
4,333
4,118
3,906
3,696
8,449
8,037
7,628
7,222
6,818
6,414
6,010
5,606
5,293
5,027
4,760
4,494
4,227
3,960
3,694
3,557
3,420
3,284
3,147
3,010
2,880
2,753
2,626
2,500
2,369
2,249
2,130
2,048
0
0
0
0002,0482,1302,2492,3692,5002,6262,7532,8803,0103,1473,2843,4203,5573,6943,9604,2274,4944,7605,0275,2935,6066,0106,4146,8187,2227,6288,0378,4493,6963,9064,1184,3334,5534,7765,0075,2415,4795,7196,1576,5967,0417,4897,9408,3938,8509,3109,77310,23910,70911,18011,65512,13312,48812,96913,45313,9429,64810,1325,9385,9626,0666,1866,3016,6916,7846,6646,0516,1255,8925,9929,3179,4179,4692,1880002,253002,4262,4260002,351002,3060001,3500001,0000
       Long-term Assets Other 
1,000
0
1,200
1,200
1,400
33
1,433
1,988
2,368
2,333
2,302
2,466
2,333
2,393
2,333
2,354
0
2,373
2,342
2,317
2,301
2,315
2,273
2,253
2,358
2,358
0
0
0
0
0
0
132
132
0
282
282
13,003
12,770
12,340
167
167
287
287
306
283
284
284
259
254
208
445
408
292
323
323
439
438
501
454
1,158
2,010
1,414
1,082
-342,571,975
582
425
344
671
1,035
1,326
1,482
2,113
1,525
1,674
2,197
2,639
2,449
2,724
2,626
2,670
2,981
2,853
2,731
2,672
2,480
2,556
17,642
25,957
25,882
1,831
1,755
1,426
1,274
770
2,832
-1,631
653
667
605
605
605605667653-1,6312,8327701,2741,4261,7551,83125,88225,95717,6422,5562,4802,6722,7312,8532,9812,6702,6262,7242,4492,6392,1971,6741,5252,1131,4821,3261,035671344425582-342,571,9751,0821,4142,0101,15845450143843932332329240844520825425928428428330628728716716712,34012,77013,00328228201321320000002,3582,3582,2532,2732,3152,3012,3172,3422,37302,3542,3332,3932,3332,4662,3022,3332,3681,9881,433331,4001,2001,20001,000
> Total Liabilities 
1,300
1,500
1,400
1,800
2,100
2,181
2,025
1,645
1,631
1,596
1,583
1,455
1,596
1,671
1,230
1,285
1,694
917
786
1,035
1,181
840
1,841
3,278
5,402
5,653
5,176
4,061
5,508
4,566
4,166
4,010
8,907
8,171
8,335
8,334
8,740
8,118
8,698
9,480
19,881
20,166
25,416
22,253
19,444
20,402
8,325
7,785
8,966
16,601
12,276
11,962
13,245
15,121
12,237
13,196
10,281
17,781
21,321
25,799
35,385
22,478
19,885
17,488
20,248
14,429
20,745
37,386
37,908
40,071
41,896
47,571
50,329
47,369
35,324
41,561
44,750
60,570
37,431
36,987
44,081
110,199
108,595
115,415
138,547
151,067
256,825
113,814
78,632
73,257
83,288
82,190
96,272
90,426
161,728
125,271
126,171
67,369
63,666
54,937
55,595
55,59554,93763,66667,369126,171125,271161,72890,42696,27282,19083,28873,25778,632113,814256,825151,067138,547115,415108,595110,19944,08136,98737,43160,57044,75041,56135,32447,36950,32947,57141,89640,07137,90837,38620,74514,42920,24817,48819,88522,47835,38525,79921,32117,78110,28113,19612,23715,12113,24511,96212,27616,6018,9667,7858,32520,40219,44422,25325,41620,16619,8819,4808,6988,1188,7408,3348,3358,1718,9074,0104,1664,5665,5084,0615,1765,6535,4023,2781,8418401,1811,0357869171,6941,2851,2301,6711,5961,4551,5831,5961,6311,6452,0252,1812,1001,8001,4001,5001,300
   > Total Current Liabilities 
1,100
1,400
1,200
1,700
2,100
2,106
1,956
1,583
1,538
1,513
1,505
1,387
1,513
1,605
1,183
1,244
1,658
884
756
1,009
1,159
824
1,831
3,274
5,402
5,310
4,849
3,749
4,136
3,235
2,858
2,735
3,268
2,705
2,973
3,106
3,354
2,855
3,547
4,455
14,710
15,074
20,034
21,246
19,350
17,688
5,672
5,225
6,437
14,184
9,941
9,704
11,043
13,015
10,231
11,276
8,377
15,978
19,071
20,438
28,966
15,641
11,604
8,928
14,024
8,159
14,520
18,278
31,466
33,399
35,495
41,375
43,823
40,003
27,382
33,364
35,405
51,375
28,406
27,998
35,300
27,415
24,079
19,547
31,989
32,295
37,982
41,263
41,706
41,539
51,749
51,376
65,742
59,360
131,064
94,915
96,868
55,151
51,932
43,711
42,570
42,57043,71151,93255,15196,86894,915131,06459,36065,74251,37651,74941,53941,70641,26337,98232,29531,98919,54724,07927,41535,30027,99828,40651,37535,40533,36427,38240,00343,82341,37535,49533,39931,46618,27814,5208,15914,0248,92811,60415,64128,96620,43819,07115,9788,37711,27610,23113,01511,0439,7049,94114,1846,4375,2255,67217,68819,35021,24620,03415,07414,7104,4553,5472,8553,3543,1062,9732,7053,2682,7352,8583,2354,1363,7494,8495,3105,4023,2741,8318241,1591,0097568841,6581,2441,1831,6051,5131,3871,5051,5131,5381,5831,9562,1062,1001,7001,2001,4001,100
       Short-term Debt 
0
0
0
0
100
53
54
55
73
69
60
38
69
20
22
22
21
0
0
-815
331
-555
-662
0
3,067
0
0
0
0
0
0
0
0
720
776
653
0
617
594
1,764
12,109
12,072
12,088
12,112
12,115
12,098
1,013
0
0
0
1,184
0
4,258
856
1,214
1,495
3,735
2,200
1,732
1,359
5,025
1,735
1,719
1,260
6,388
1,407
2,740
3,140
11,754
4,467
5,398
7,616
20,492
6,527
7,870
8,689
25,203
9,357
14,149
0
0
1,889
1,949
2,011
2,075
2,132
2,200
2,264
2,329
2,396
2,464
2,536
2,604
2,673
2,738
2,821
2,804
18,975
19,060
2,118
19,177
19,1772,11819,06018,9752,8042,8212,7382,6732,6042,5362,4642,3962,3292,2642,2002,1322,0752,0111,9491,8890014,1499,35725,2038,6897,8706,52720,4927,6165,3984,46711,7543,1402,7401,4076,3881,2601,7191,7355,0251,3591,7322,2003,7351,4951,2148564,25801,1840001,01312,09812,11512,11212,08812,07212,1091,7645946170653776720000000003,0670-662-555331-815002122222069386069735554531000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,889
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,395
16,708
16,488
16,771
16,77116,48816,70816,3950000000000000001,889000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,100
1,400
1,200
1,700
1,800
1,784
1,633
1,277
1,321
1,394
1,423
1,330
625
1,154
684
628
1,033
682
560
815
828
555
662
378
677
1,673
1,891
1,303
1,865
1,579
1,430
1,445
555
1,475
1,649
1,894
1,807
1,365
1,881
1,478
377
2,266
41
594
1,568
3,345
3,158
3,495
1,564
3,337
3,243
4,710
1,140
3,317
3,523
3,134
1,040
2,945
3,382
4,515
2,388
6,030
5,991
4,792
2,031
4,450
9,485
13,332
4,457
12,310
13,309
16,677
6,993
14,995
17,325
23,310
8,492
17,124
13,211
18,016
11,022
16,960
14,042
10,247
7,649
11,283
17,729
24,328
1,468
26,743
31,869
29,147
24,762
39,523
39,575
74,148
80,907
26,169
10,356
3,904
4,648
4,6483,90410,35626,16980,90774,14839,57539,52324,76229,14731,86926,7431,46824,32817,72911,2837,64910,24714,04216,96011,02218,01613,21117,1248,49223,31017,32514,9956,99316,67713,30912,3104,45713,3329,4854,4502,0314,7925,9916,0302,3884,5153,3822,9451,0403,1343,5233,3171,1404,7103,2433,3371,5643,4953,1583,3451,568594412,2663771,4781,8811,3651,8071,8941,6491,4755551,4451,4301,5791,8651,3031,8911,6736773786625558288155606821,0336286841,1546251,3301,4231,3941,3211,2771,6331,7841,8001,7001,2001,4001,100
       Other Current Liabilities 
0
0
0
0
200
269
269
251
144
536
22
19
953
1,490
337
393
402
202
196
815
-331
555
662
1,824
607
2,554
1,350
1,103
1,064
656
504
614
2,130
69
69
62
574
405
524
716
1,614
161
5,212
7,673
5,397
1,718
1,049
4,365
5,641
13,544
4,868
9,230
5,176
8,417
5,039
6,163
2,860
10,255
13,454
14,096
19,541
6,046
3,107
2,207
2,023
1,733
1,710
1,094
1,301
1,707
1,815
1,813
1,168
1,051
1,364
940
361
750
229
9,721
24,021
8,453
7,872
7,118
22,142
18,812
17,944
14,593
37,861
12,346
17,307
19,615
38,354
17,149
79,769
17,946
13,157
10,007
3,749
41,593
18,745
18,74541,5933,74910,00713,15717,94679,76917,14938,35419,61517,30712,34637,86114,59317,94418,81222,1427,1187,8728,45324,0219,7212297503619401,3641,0511,1681,8131,8151,7071,3011,0941,7101,7332,0232,2073,1076,04619,54114,09613,45410,2552,8606,1635,0398,4175,1769,2304,86813,5445,6414,3651,0491,7185,3977,6735,2121611,6147165244055746269692,1306145046561,0641,1031,3502,5546071,824662555-3318151962024023933371,49095319225361442512692692000000
   > Long-term Liabilities 
200
100
200
100
100
75
69
63
94
83
78
68
83
66
47
41
36
33
30
27
23
16
10
4
1,728
343
327
312
1,372
1,331
1,308
1,275
5,639
5,466
5,362
5,228
5,386
5,263
5,151
5,024
5,171
5,092
5,382
1,007
94
2,714
2,653
2,560
2,530
2,417
2,335
2,259
2,202
2,107
2,006
1,920
1,905
1,803
2,250
5,361
6,418
6,837
8,281
8,561
6,224
6,270
6,225
19,108
6,441
6,672
6,401
6,197
6,506
7,366
7,942
8,197
9,345
9,195
9,025
8,989
8,781
82,784
84,516
95,868
106,557
118,772
218,843
72,551
36,926
31,718
31,539
30,814
30,530
31,066
30,664
30,356
29,302
12,218
11,734
27,715
13,025
13,02527,71511,73412,21829,30230,35630,66431,06630,53030,81431,53931,71836,92672,551218,843118,772106,55795,86884,51682,7848,7818,9899,0259,1959,3458,1977,9427,3666,5066,1976,4016,6726,44119,1086,2256,2706,2248,5618,2816,8376,4185,3612,2501,8031,9051,9202,0062,1072,2022,2592,3352,4172,5302,5602,6532,714941,0075,3825,0925,1715,0245,1515,2635,3865,2285,3625,4665,6391,2751,3081,3311,3723123273431,7284101623273033364147668368788394636975100100200100200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,563
62,757
74,578
77,023
98,596
199,359
53,689
0
14,070
14,536
14,479
0
16,208
16,521
16,301
16,615
0
0
0
0
000016,61516,30116,52116,208014,47914,53614,070053,689199,35998,59677,02374,57862,75760,563000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
10
17
25
31
35
39
42
45
45
37
38
36
33
30
27
22
16
10
4
0
343
327
312
296
270
263
246
4,626
4,469
4,380
4,262
4,435
4,329
4,232
4,121
4,284
4,220
126
167
94
2,714
2,652
2,560
2,476
2,364
2,282
2,205
2,123
2,028
1,927
1,841
1,741
1,638
2,086
5,197
6,222
6,641
8,085
8,365
5,719
5,766
5,721
18,604
6,266
6,496
6,224
6,020
6,331
7,191
7,766
8,022
9,320
9,195
9,025
8,989
8,781
231
275
4,840
9,125
22,382
120,019
192
206
209
205
202
111
93
89
742
32
0
32
32
0
032320327428993111202205209206192120,01922,3829,1254,8402752318,7818,9899,0259,1959,3208,0227,7667,1916,3316,0206,2246,4966,26618,6045,7215,7665,7198,3658,0856,6416,2225,1972,0861,6381,7411,8411,9272,0282,1232,2052,2822,3642,4762,5602,6522,714941671264,2204,2844,1214,2324,3294,4354,2624,3804,4694,6262462632702963123273430410162227303336383745454239353125171000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,335
2,259
2,202
2,107
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
374
366
318
227
206
165
216
203
0
0
0
25
27
27
0
32
32
32
0
32
32
32
0
32
32
32
32
32
32
0
0
0032323232323203232320323232027272500020321616520622731836637400000000000000002,1072,2022,2592,33500000000000000000000000000000000000000000000000000
> Total Stockholder Equity
10,800
8,300
16,800
14,800
13,100
11,831
10,687
9,366
7,552
9,888
7,324
5,609
4,963
4,963
6,651
5,266
3,725
4,062
2,867
8,917
15,048
14,844
22,835
19,349
15,550
17,228
14,973
11,855
23,471
21,412
18,860
15,893
21,693
23,747
36,018
32,531
31,035
27,599
23,567
21,002
19,106
15,818
37,191
67,531
60,562
58,704
51,334
50,918
46,503
57,665
55,008
50,745
47,315
39,692
35,833
30,765
34,355
39,932
29,197
61,755
52,455
128,742
121,836
116,733
111,227
103,117
180,562
193,140
175,687
170,972
161,994
146,882
123,282
105,849
123,433
162,023
142,393
112,998
111,396
103,613
86,936
77,909
53,617
33,694
3,435
184,325
186,264
323,904
461,141
581,606
508,554
453,572
399,669
355,085
297,671
266,697
222,363
199,214
169,372
138,160
117,349
117,349138,160169,372199,214222,363266,697297,671355,085399,669453,572508,554581,606461,141323,904186,264184,3253,43533,69453,61777,90986,936103,613111,396112,998142,393162,023123,433105,849123,282146,882161,994170,972175,687193,140180,562103,117111,227116,733121,836128,74252,45561,75529,19739,93234,35530,76535,83339,69247,31550,74555,00857,66546,50350,91851,33458,70460,56267,53137,19115,81819,10621,00223,56727,59931,03532,53136,01823,74721,69315,89318,86021,41223,47111,85514,97317,22815,55019,34922,83514,84415,0488,9172,8674,0623,7255,2666,6514,9634,9635,6097,3249,8887,5529,36610,68711,83113,10014,80016,8008,30010,800
   Common Stock
0
0
0
0
0
30,492
42,258
42,287
42,287
47,639
34
34
34
89
40
40
50
50
51
53
64
70
70
18
18
19
19
19
29
30
31
31
36
39
44
44
44
44
44
44
44
44
86
102
103
103
103
103
105
127
127
127
135
135
135
137
144
180
180
208
210
240
60
60
61
61
72
72
72
72
73
74
74
75
78
90
90
91
91
94
97
98
99
99
101
146
159
168
187
209
210
210
217
227
248
249
253
263
268
270
23
232702682632532492482272172102102091871681591461019999989794919190907875747473727272726161606024021020818018014413713513513512712712710510310310310310286444444444444444439363131302919191918187070645351505040408934343447,63942,28742,28742,25830,49200000
   Retained Earnings -1,622,965-1,597,961-1,564,032-1,528,497-1,487,848-1,433,385-1,395,601-1,287,103-1,209,856-1,102,908-1,042,739-960,599-906,197-881,858-901,030-772,327-739,786-702,124-679,033-649,646-620,426-587,131-562,115-555,476-523,356-501,850-467,716-458,236-434,838-408,605-387,845-369,141-361,098-343,146-348,740-342,492-331,910-324,499-317,321-306,610-295,789-280,334-249,457-238,604-229,760-229,101-222,479-218,346-210,091-204,615-200,073-197,251-194,838-188,545-187,135-179,518-177,224-169,879-166,930-156,277-152,813-149,237-146,893-142,869-139,847-141,939-137,318-132,841-128,755-123,500-120,059-116,976-114,270-102,712-99,521-97,193-87,907-83,894-80,224-77,882-76,202-62,474-54,546-53,148-53,327-51,752-50,361-47,362-38,239-45,396-43,684-38,239-35,569-33,409-31,506-29,598-27,200-25,200-22,900-20,000-17,400
   Accumulated Other Comprehensive Income 
-600
-700
-700
11,000
11,000
10,902
-102
-102
244
-102
-102
-102
-1,555
-102
3,707
3,718
-102
-1,785
-1,785
-7,500
-1,960
-1,960
-1,960
-1,960
-2,012
-3
-16
-16
-30
-17
-47
-66
-49
56
67
117
108
-674
-915
-1,422
6
22
45
87
106
111
109
117
3
1
-3
-5
35
65
65
93
73
67
-96
-98
-76
-72
-47
-110
-251
-192
-324
3,654
2,708
2,909
3,514
2,659
1,328
782
1,181
560
-117
-461
-598
-282
-529
290
732
700
473
-1,457
-610
-248
-256
-266
-266
-258
-282
-458
-650
-885
-699
-583
-691
-751
-663
-663-751-691-583-699-885-650-458-282-258-266-266-256-248-610-1,457473700732290-529-282-598-461-1175601,1817821,3282,6593,5142,9092,7083,654-324-192-251-110-47-72-76-98-96677393656535-5-3131171091111068745226-1,422-915-6741081176756-49-66-47-17-30-16-16-3-2,012-1,960-1,960-1,960-1,960-7,500-1,785-1,785-1023,7183,707-102-1,555-102-102-102244-102-10210,90211,00011,000-700-700-600
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
254,956
255,238
257,236
257,839
258,113
259,636
263,897
278,290
278,570
341,980
348,110
435,183
439,145
441,281
443,328
445,739
529,555
532,559
534,005
537,131
546,251
552,753
556,718
563,229
589,891
663,223
665,776
668,845
674,017
690,931
707,794
727,167
731,819
735,018
742,647
957,963
1,087,745
1,205,843
1,367,407
1,542,261
1,551,348
1,556,528
1,609,590
1,642,420
1,693,674
1,700,717
1,710,656
1,728,031
1,733,826
0
0
001,733,8261,728,0311,710,6561,700,7171,693,6741,642,4201,609,5901,556,5281,551,3481,542,2611,367,4071,205,8431,087,745957,963742,647735,018731,819727,167707,794690,931674,017668,845665,776663,223589,891563,229556,718552,753546,251537,131534,005532,559529,555445,739443,328441,281439,145435,183348,110341,980278,570278,290263,897259,636258,113257,839257,236255,238254,95600000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
28,800
29,000
40,400
29,000
29,300
36
36
590
590
590
51,077
51,074
0
52,338
53,265
53,260
57,104
58,945
59,147
78,838
93,146
94,616
104,948
105,185
105,451
114,403
114,489
114,561
137,740
138,374
138,934
139,427
150,460
156,493
173,226
174,310
170,731
171,098
171,331
171,617
171,869
172,030
203,990
237,221
237,578
238,008
238,257
239,243
241,233
254,787
254,956
255,238
257,236
257,839
258,113
259,636
263,897
278,290
278,570
341,980
348,110
435,183
439,145
441,281
443,328
445,739
529,555
532,559
534,005
537,131
546,251
552,753
556,718
563,229
589,891
663,223
665,776
668,845
674,017
690,931
707,794
727,167
731,819
735,018
742,647
957,963
1,087,745
1,205,843
1,367,407
1,542,261
1,551,348
1,556,528
1,609,590
1,642,420
1,693,674
1,700,717
1,710,656
1,728,031
1,733,826
1,736,603
1,740,954
1,740,9541,736,6031,733,8261,728,0311,710,6561,700,7171,693,6741,642,4201,609,5901,556,5281,551,3481,542,2611,367,4071,205,8431,087,745957,963742,647735,018731,819727,167707,794690,931674,017668,845665,776663,223589,891563,229556,718552,753546,251537,131534,005532,559529,555445,739443,328441,281439,145435,183348,110341,980278,570278,290263,897259,636258,113257,839257,236255,238254,956254,787241,233239,243238,257238,008237,578237,221203,990172,030171,869171,617171,331171,098170,731174,310173,226156,493150,460139,427138,934138,374137,740114,561114,489114,403105,451105,185104,94894,61693,14678,83859,14758,94557,10453,26053,26552,338051,07451,077590590590363629,30029,00040,40029,00028,800



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue832
Cost of Revenue-3,504
Gross Profit-2,672-2,672
 
Operating Income (+$)
Gross Profit-2,672
Operating Expense-132,555
Operating Income-135,227-135,227
 
Operating Expense (+$)
Research Development88,477
Selling General Administrative47,582
Selling And Marketing Expenses3,504
Operating Expense132,555139,562
 
Net Interest Income (+$)
Interest Income8,203
Interest Expense-1,223
Other Finance Cost-31
Net Interest Income6,949
 
Pretax Income (+$)
Operating Income-135,227
Net Interest Income6,949
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-135,117-135,336
EBIT - interestExpense = -136,449
-135,117
-133,895
Interest Expense1,223
Earnings Before Interest and Taxes (EBIT)-135,227-133,895
Earnings Before Interest and Taxes (EBITDA)-131,723
 
After tax Income (+$)
Income Before Tax-135,117
Tax Provision-0
Net Income From Continuing Ops-164,577-135,117
Net Income-135,117
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses136,059
Total Other Income/Expenses Net109-6,949
 

Technical Analysis of Inovio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inovio. The general trend of Inovio is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inovio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inovio Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.20 < 16.56 < 16.68.

The bearish price targets are: 12.79 > 10.10 > 8.3486.

Tweet this
Inovio Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inovio Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inovio Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inovio Pharmaceuticals Inc. The current macd is 1.20732916.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inovio price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Inovio. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Inovio price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Inovio Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartInovio Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inovio Pharmaceuticals Inc. The current adx is 38.29.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Inovio shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Inovio Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inovio Pharmaceuticals Inc. The current sar is 10.35.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Inovio Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inovio Pharmaceuticals Inc. The current rsi is 77.79. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Inovio Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartInovio Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inovio Pharmaceuticals Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inovio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Inovio Pharmaceuticals Inc Daily Stochastic Oscillator ChartInovio Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inovio Pharmaceuticals Inc. The current cci is 193.19.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Inovio Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartInovio Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inovio Pharmaceuticals Inc. The current cmo is 67.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Inovio Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartInovio Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inovio Pharmaceuticals Inc. The current willr is -17.64705882.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Inovio Pharmaceuticals Inc Daily Williams %R ChartInovio Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inovio Pharmaceuticals Inc. The current atr is 1.02529307.

Inovio Pharmaceuticals Inc Daily Average True Range (ATR) ChartInovio Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inovio Pharmaceuticals Inc. The current obv is -379,961.

Inovio Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartInovio Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inovio Pharmaceuticals Inc. The current mfi is 82.18.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Inovio Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartInovio Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inovio Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Inovio Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inovio Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5077.791
Ma 20Greater thanMa 5011.048
Ma 50Greater thanMa 1008.622
Ma 100Greater thanMa 2007.155
OpenGreater thanClose13.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Inovio with someone you think should read this too:
  • Are you bullish or bearish on Inovio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inovio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inovio Pharmaceuticals Inc

I send you an email if I find something interesting about Inovio Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Inovio Pharmaceuticals Inc.

Receive notifications about Inovio Pharmaceuticals Inc in your mailbox!